Drug-induced catatonia

Drugs of Today

Volumn 41, Issue 9, 2005, Pages 599-607

  Duggal, Harpreet S ^a   Singh, Ira ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ABACAVIR; ACETYLSALICYLIC ACID; ALLOPURINOL; AMANTADINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CIPROFLOXACIN; DANTROLENE; DISULFIRAM; FLUMAZENIL; LITHIUM; LORAZEPAM; MAPROTILINE; MEMANTINE; METHYLPHENIDATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEDATIVE AGENT; STEROID; VALPROIC ACID; ZIPRASIDONE;

CATATONIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; ELECTROCONVULSIVE THERAPY; HUMAN; LABORATORY TEST; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CATATONIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; PREVALENCE; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 29144480017     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.9.899610     Document Type: Review

References (70)

1. Fink, M., Taylor, M.A. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge University Press, Cambridge, UK 2003.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. American Psychiatric Association, Washington, D.C., 1994.
3. Bush, G., Fink, M., Petrides, G., Dowling, F., Francis, A. Catatonia I: Rating scale and standardized examination. Acta Psychiatr Scand 1996, 93: 129-36.
4. Carroll, B.T., Anfinson, T.J., Kennedy, J.C., Yendrek, R., Boutros, M., Bilon, A. Catatonic disorder due to general medical conditions. J Neuropsychiatry Clin Neurosci 1994, 6: 122-33.
5. Carroll, B.T., Kennedy, J.C., Goforth, H.W. Catatonic signs in medical and psychiatric conditions. CNS Spectr 2000, 5: 66-9.
6. Huang, T.L., Ree, S.C., Huang, Y.C., Liu, H.Y., Yang, Y.Y. Catatonic features: Differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci 1999, 53: 63-6.
7. Mahendra, B. Where have all the catatonics gone? Psychol Med 1981, 11: 669-71.
8. Levenson, J.L., Pandurangi, A.K. Prognosis and complications. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington D.C., 2004, 161-72.
9. Lazarus, A., Mann, S.C., Caroff, S.N. The Neuroleptic Malignant Syndrome and Related Conditions. American Psychiatric Press, Inc., Washington, D.C., 1989.
10. May, R.H. Catatonic-like states following phenothiazine therapy. Am J Psychiatry 1959, 115: 1119-20.
11. Rifkin, A., Quitkin, F., Klein, D.F. Akinesia: A poorly recognized drug-induced extrapyramidal behavioral disorder. Arch Gen Psychiatry 1975, 32: 672-4.
12. Behrman, S. Mutism induced by phenothiazines. Br J Psychiatry 1972, 121: 599-604.
13. Gelenberg, A.J., Mandel, M.R. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977, 34: 947-50.
14. Fricchione, G.L., Cassem, N.H., Hooberman, D., Hobson, D. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983, 3: 338-42.
15. Lopez-Canino, A., Francis, A. Drug-induced catatonia. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington, D.C., 2004, 129-39.
16. Bahro, M., Kampf, C., Strnad, J. Catatonia under medication with risperidone in a 61-year-old patient. Acta Psychiatr Scand 1999, 99: 223-6.
17. Biancosino, B., Zanchi, P., Agostini, M., Grassi, L. Suspected neuroleptic catatonia induced by clozapine. Can J Psychiatry 2001, 46: 458.
18. Jackson, C.W., Head, L.A., Kellner, C.H. Catatonia associated with bupropion treatment. J Clin Psychiatry 1992, 53: 210.
19. Herrmann, N., Lieft, S.J. Drug-induced catatonia. Can J Psychiatry 1988, 33: 633-4.
20. Cohen, D., Flament, M., Dubos, P.P., Basquin, M.K. Case series: Catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 1999, 38: 1040-6.
21. Lauterbach, E.C. Catatonia-like events after valproic acid with risperidone and sertraline. Neuropsychiatry Neruopsychol Behav Neurol 1998, 3: 157-63.
22. Shad, M.U., Preskorn, S.H., Izgur, Z. Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder. J Clin Psychopharmacol 2000, 20: 390-2.
23. Glover, S.G., Escalona, R., Bishop, J., Saldivia, A. Catatonia associated with lorazepam withdrawal. Psychosomatics 1997, 38: 148-50.
24. Kasture, S.B., Mandhane, S.N., Chopde, C.T. Baclofen-induced catatonia: Modification by serotonergic agents. Neuropharmacology 1996, 35: 595-8.
25. Sullivan, B.J., Dickerman, J.D. Steroid-associated catatonia: Report of a case. Pediatrics 1979, 63: 677-9.
26. Perry, P., Tsuang, M., Hwang, M. Prednisolone psychosis: Clinical observations. Drug Intell Clin Pharm 1984, 18: 603-9.
27. Doherty, M., Garstin, R., McClelland, R.J., Rowlands, B.J., Collins, B.J. A steroid stupor in surgical ward. Br J Psychiatry 1991, 158: 125-7.
28. Ilbeigi, M.S., Davidson, M.L., Yarmush, J.M. An unexpected arousal of etomidate in a patient on high-dose steroids. Anesthesiology 1998, 89: 1587-9.
29. Schmuecker, J.D., Meloy, J.R., Haroun, A. Disulfiram toxicity and catatonia in a forensic outpatient. Am J Psychiatry 1992, 149: 1275-6.
30. Akhtar, S., Ahmad, H. Ciprofloxacilin-induced catatonia. J Clin Psychiatry 1993, 54: 115-6.
31. Breakey, W.R., Kala, A.K. Typhoid catatonia responsive to ECT. BMJ 1977, 2: 357-9.
32. Hafeiz, H.B. Psychiatric manifestation of enteric fever. Acta Psychiatr Scand 1987, 75: 69-3.
33. Ahuja, N. Organic catatonia: A review. Indian J Psychiatry 2000, 42: 327-46.
34. Atri, P.B., Julius, D.A. Maprotiline hydrochloride associated with clinical state of stupor and epileptic encephalogram. J Clin Psychopharmacol 1984, 4: 207-9.
35. Sackellares, J.C. Stupor following administration of valproic acid to patient receiving other antiepileptic drugs. Epilepsia 1979, 20: 697-703.
36. Ezrin-Waters, C., Miller, P., Seeman, P. Catalepsy induced by morphine or haloperidol: Effects of apomorphine and anticholinergic drugs. Can J Physiol Pharmacol 1976, 54: 516-9.
37. Wetzel, H., Heuser, I., Benkert, O. Stupor and affective state: Alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 1987, 175: 240-2.
38. Collins, C.E., Thomas, D.J., Gumpel, J.M. Catatonia in the allopurinol hypersensitivity syndrome. BMJ 1991, 302: 970.
39. Foster, R., Olajide, D., Everall, I.P. Antiretroviral therapy-induced psychosis: A case report and brief review of the literature. HIV Med 2003, 4: 139-4.
40. Rosebush, P.I., Mazurek, M.F. Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 1996, 16: 315-9.
41. Deuschle, M., Lederbogen, F. Benzodiazepine withdrawal-induced catatonia. Pharmacopsychiatry 2001, 34: 41-2.
42. Ungvari, G.S., Kau, L.S., Wai-Kwong, T., Shing, N.F. Eur Arch Psychiatry Clin Neurosci 2001, 251 (Suppl. 1): 31-4.
43. Good, M.I. Catatonialike symptomatology and withdrawal dyskinesias. Am J Psychiatry 1976, 133: 1454-6.
44. Carroll, B.T. Catatonia due to mixed sedative withdrawal. J Neuropsychiatr 1997, 9: 303-4.
45. Yeh, A.W.C., Lee, J.W.Y., Cheng, T.C., Wen, J.K., Chen, W.H. Clozapine-withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity. Clin Neuropharmacol 2004, 27: 216-8.
46. Rosebush, P.I., MacQueen, G.M., Mazurek, M.F. Catatonia following gabapentin withdrawal. J Clin Psychopharmacol 1999, 19: 188-9.
47. McCarron, M.M., Schulze, B.W., Thompson, G.A., Conder, M.C., Goetz, W.A. Acute phencyclidine intoxication: Clinical patterns, complications, and treatment. Ann Emerg Med 1981, 10: 290-7.
48. Gingrich, J.A., Rudnick-Levin, F., Almeida, C., Innes, L., Schneier, H. Cocaine and catatonia. Am J Psychiatry 1998, 155: 1629.
49. Maxwell, D.L., Polkey, M.I., Henry, J.A. Hyponatremia and catatonic stupor after taking "ecstasy". BMJ 1993, 307: 1399.
50. Masi, G., Mucci, M., Floriani, C. Acute catatonia after a single dose of ecstasy. J Am Acad Child Adolesc Psychiatry 2002, 41: 892.
51. Atre-Vaidya, N. Significance of abnormal brain perfusion in catatonia: A case report. Neuropsychiatry Neuropsychol Behav Neurol 2000, 13: 136-9.
52. Kanes, S.J. Animal models. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington, D.C., 2004, 189-200.
53. Stevens, J., Wilson, K., Foote, W. GABA-blockade, dopamine and schizophrenia: Experimental studies in the cat. Psychopharmacologia 1974, 39: 105-19.
54. Carroll, B.T. The universal field hypothesis of catatonia and neuroleptic syndrome. CNS Spectr 2000, 5: 26-33.
55. Parmar, M.S. Akinetic mutism after baclofen. Ann Int Med 1991, 115: 499-500.
56. Northoft, G., Eckert, J., Fritze, J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatr 1997, 62: 404-6.
57. Koch, M., Chandragiri, S., Rizvi, S., Petrides, G., Francis, A. Catatonic signs in neuroleptic malignant syndrome. Compr Psychiatry 2000, 41: 73-5.
58. Castillo, E., Rubin, R.T., Holsboer-Traschler, E. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 1989, 146: 324-8.
59. Kontaxakis, V.P., Vaidakis, N.M., Christodoulou, G.N., Valergaki, H.C. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? Neuropsychobiology 1990, 23: 38-40.
60. White, D.A.C., Robins, A.M. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS Spectr 2000, 5: 58-65.
61. Carroll, B.T., Goforth, H.W. Medical catatonia. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington, D.C., 2004, 121-7.
62. Lee, J.W.Y. Laboratory findings. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington, D.C., 2004, 65-75.
63. Northoff, G. Neuroimaging and neurophysiology. In: Caroff, S.N., Mann, S.C., Francis, A., Fricchione, G.L. (Eds.). Catatonia: Psychopathology to Neurobiology. American Psychiatric Publishing, Inc., Washington, D.C., 2004, 77-91.
64. Rosebush, P.I., Hilderbrand, A.M., Furlong, B.G., Mazurek, M.F. Catatonic syndrome in a general psychiatric inpatient population: Frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51: 357-62.
65. Fricchione, G., Mann, S.C., Caroff, S.N. Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatr Ann 2000, 30: 347-55.
66. Pennati, A., Sacchetti, E., Calzeroni, A. Dantrolene in lethal catatonia. Am J Psychiatry 1991, 148: 28.
67. Grisaru, N., Chudakov, B., Yaroslavsky, Y., Belmaker, R.H. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry 1998, 155: 160.
68. Carroll, B.T., Thomas, C., Jayanti, K., Hawkins, J.M., Burbage, C. Treating persistent catatonia when benzodiazepines fail. Current Psychiatry 2005, 4: 56-64.
69. Levy, W.O., Nuñez, C.Y. Use of ziprasidone to treat bipolar-associated catatonia. Bipolar Disord 2004, 6: 166-7.
70. Duggal, H.S., Gandotra, G. Risperidone treatment of periodic catatonia. Can J Psychiatry 2005, 50: 241-2.